& Williams, J
Anne Marie Morse Explains How GLP-1 Drugs Treat Obstructive Sleep Apnea docwirenews.com GLP-1 Drugs for Sleep Apnea WebMD The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review MDPI GLP-1 and Insulin Agonists for Obstructive Sleep Apnea European Society of Medicine Clinical Practice Guideline Summary for Clinicians: The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea NIH Provider Fact Sheet Obesity and Obstructive Sleep Apnea aasm.org The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
Several large clinical studies, the majority of which are cardiovascular outcome trials, indicate that GLP-1 RA therapy is safe and tolerable for people living with T2DM and compromised renal function, and also suggest that GLP-1 RAs may have renoprotective properties
Aim for a minimum of 0.7 to 1.0 grams of protein per pound of lean body mass daily
Cyanidin-3-glucoside (C3G), an anthocyanin, can attenuate acute organ injury and modulate oxidation, which markedly ameliorated Era-induced ferroptosis, resulting in nearly equivalent effects as selective ferroptosis inhibitor Lip-1 [78]